Total Funding
17
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
59536
EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
Acquired by 
Revolution Medicines
Peter Bach: Co-Founder
Sandra Horning: Co-Founder
About the Company
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.
By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company
seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.
The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.
Women Founded
